Stock AKYA AKOYA BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Akoya Biosciences, Inc.

Equities

AKYA

US00974H1041

Real-time Estimate Cboe BZX
Other stock markets
 20:07:11 06/05/2024 BST 		5-day change 1st Jan Change
4.115 USD +1.86% Intraday chart for Akoya Biosciences, Inc. +6.74% -15.57%
05-02 Akoya Biosciences and Shanghai KR Pharmtech Announces Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows CI
04-05 Akoya Biosciences Showcases Spatial Biology 2.0 Solutions At AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
GL
Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
AQ
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows
GL
Akoya Biosciences and Shanghai KR Pharmtech Announces Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows
CI
Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024
GL
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
GL
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions At AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
CI
Akoya Biosciences Names BostonGene as a Qualified CRO Service Provider
AQ
JPMorgan Adjusts Price Target on Akoya Biosciences to $10 From $12, Maintains Overweight Rating
MT
UBS Adjusts Akoya Biosciences Price Target to $7.50 From $7, Maintains Buy Rating
MT
Akoya Biosciences, Inc. Provides Revenue Guidance for the Full Year 2024
CI
Transcript : Akoya Biosciences, Inc., Q4 2023 Earnings Call, Mar 04, 2024
Akoya: Q4 Earnings Snapshot
AQ
Earnings Flash (AKYA) AKOYA BIOSCIENCES Posts Q4 Revenue $26.5M, vs. Street Est of $26.1M
MT
Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook
GL
Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook
AQ
Akoya Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
North American Morning Briefing : Stock Futures -2-
DJ
Transcript : Akoya Biosciences, Inc. - Special Call
Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AKYA Stock
  4. News Akoya Biosciences, Inc.